One PHP/IOP/OP Mental Health Facility and One Residential Detox/SUD Facility for Sale in Prime Location on the West Coast

American HealthCare Capital is pleased to exclusively present two mental health treatment facilities for sale in a prime location on the west coast. Both facilities are licensed/certified by DHCS and are Joint Commission Accredited.

One facility is exclusively outpatient and offers nationwide PHP, IOP, and OP services for up to thirty clients. Programs are designed to address a wide variety of complex trauma and behavioral concerns in a supportive, highly individualized environment. The other facility is residential and focuses on drug and alcohol addiction treatment, as well as clinical care for co-occurring mental health issues, in a small, luxurious, private setting. Both are long-established, highly respected and widely regarded as leaders in the industry with exceptional reputations.

Financial Overview

Combined revenues for both facilities in 2024 totaled $4.6 million, and the company is on pace to equal or exceed that amount in 2025. Adjusted EBITDA for both was $1.1 million.  Opportunities for growth abound, especially given the company’s stellar reputation and differentiated offerings. The real estate associated with the residential facility can be purchased at an additional cost. There are also separate, luxury supportive living homes independent from the business, one with a sober living permit, that are available for lease or purchase should a buyer desire any of them.

Staff Overview

The outstanding staff is expected to stay post-sale, and the owners will work closely with the new buyer to ensure a smooth transition.

Asking Price

The asking price is To Be Determined based on whether a buyer would like to purchase one or both businesses, and whether the buyer would like to purchase any or all of the real estate.

Strategic Growth Partner Sought for Rapidly Expanding Northeast Behavioral Health Network

Platform Snapshot & Services

American HealthCare Capital is the exclusive advisor for a multi-site behavioral health platform based in the Northeastern United States. The organization delivers a broad mix of services: individual, couples, and group therapy, talk therapy, ADHD care, TMS, Spravato, diagnostic evaluations and assessments, and medication management. The group also supports enterprise clients operating in high-intensity corporate settings and correctional facilities.

Care is delivered through seven brick-and-mortar clinics, with two additional practices under LOI, complemented by an extensive telehealth footprint.

Patients & Access

The platform actively serves six thousand patients. Daily throughput averages roughly 200 visits, with about 10% first-time appointments. The patient mix is approximately 93% adults and 7% pediatric, supported by licensed clinicians focused on measurable quality-of-life improvements.

Financial Summary

Payor mix: 88% Commercial, 6% Medicare, 6% Self-Pay.

Revenue trajectory: $2.5M (2024), $4.7M (2025E), $7.6M (2026E).

Profitability: EBITDA of $0.4M (2024), $0.8M (2025E), and $1.3M (2026E).

Mid-year performance: gross revenue up 60% YTD (through Q2 2025) vs. 2024.

Even without incremental growth investment, the platform is positioned to deliver a +20% EBITDA margin. Management plans to continue opening new clinics. At scale, anticipated production from new locations and hires is 350 daily visits and $10 million in revenue, excluding contributions from TMS and Spravato.

Growth Plan & Market Position

Signed pipeline of add-ons and over 10 locations targeted in active review supports a regional roll-up. Demand for behavioral health continues to rise, with waitlists validating market need. Active recruiting across Psychiatrists, NPs, PAs, Psychologists, and Therapists sustains access and growth. Established local brand recognition provides a strong base for further market penetration.

Team & Leadership

Approximately 70 team members power the platform, including around 40 clinicians and 30 non-clinical professionals (including centralized RCM, credentialing, CRM, digital/web, bookkeeping, and software). The physician-founder and CEO, a seasoned clinical entrepreneur with a prior platform exit to mid-market PE, intends to remain in place to drive scale and partner on a future exit. The full team is expected to stay on post-investment.

Transaction Considerations

Investment Highlights:

Expansion runway: over 10 locations and a few add-on locations under LOI.

Strong demand signal: persistent waitlist for new intakes across markets.

Rapid financial momentum: 60% YoY gross revenue growth as of Q2 2025.

Experienced leadership: physician-founder previously built and exited a Mid-Atlantic mental health platform to a respected mid-market PE buyer.

Scalable operating engine: integrated RCM, marketing, customer experience, and technology.

Asking Price and Deal Structure

The company is seeking a strategic or capital partner with the resources to accelerate growth. Valuation will be determined through negotiations and will exclude accounts receivable, cash, and any real estate. The seller is open to flexible structures, including a majority recapitalization with rolling equity.

$1.6 Million EBITDA, Highly Profitable and Scalable Full Service Dental Laboratory Located on the Upper East Coast

American HealthCare Capital is pleased to exclusively represent a well-established, 40 year old, highly profitable Dental Laboratory located on the east coast of United States. This dental lab has been in business for almost 4 decades and serves both smaller dental practices as well large dental groups (DSO’s) on the east coast. The Company serves smaller solo-dentist practices and large dental groups (DSO’s) with the largest customer base in New Jersey, followed by Pennsylvania and New York.

This dental lab has leveraged both in-house and offshore manufacturing for the past 40 years to attain extremely healthy profit margins (much higher than average U.S. dental labs), and a very strong balance sheet. The Company continues to show stellar growth with the introduction of 3-D printers and milling. They began investing in digital scanners, 3D printers, and milling machines to increase operational efficiencies, and they currently have 3 digital scanners and two 3-D printers.

Financial Overview

Historically, the company has always been highly profitable with very strong financial performance and balance sheet. The company has no debt.  It has been investing in digital workflow and technologies, and it has developed its own unique tool to reduce the time and cost of fabricating implant-related prostheses while enjoying spectacular profits. The company is on track to achieve a revenue of nearly $5 million in 2025 with an adjusted EBITDA of $1.6 million.

Transition Plan

The owner is at retirement age and is looking for a transition of his legacy. He is open to staying on and retaining up to 20% equity with a qualified buyer.

Asking Price

The asking price for this investment opportunity is $11 million. The price excludes working capital inventory, any cash, and accounts receivable and real estate. The Seller is open to remaining in business and retain up to 20% equity with a suitable buyer experiences in scaling companies.

$6.4 Million Revenue Private Duty Home Care Agency in New Jersey

American Healthcare Capital is pleased to exclusively offer a well-established private duty home care agency in New Jersey. Founded in 2013, the agency has built a strong reputation for high quality personal care services. They provide non-medical, personal care services to those individuals who need assistance in daily living due to age, health, and cognitive related impairments. Hourly and live-in services are provided using employees of the agency. The practice primarily serves a senior population, with approximately 122 clients.

Financial Overview

Over the past year, the company has experienced significant revenue growth while maintaining profitability. In 2022, the company generated $3,575,387 in gross annual revenue with an adjusted EBITDA of $425,402. In 2023, revenue increased by approximately 3.43%, reaching $3,696,119 with an adjusted EBITDA of $628,389. In 2024, the company saw an additional increase of approximately 3.98%, collecting $3,845,156 in gross annual revenue with an adjusted EBITDA of approximately $892,000. Year-to-date 2025 financials are demonstrating continued growth and profitability with an average monthly revenue of $530,403, putting them on pace to reach $6.4 million by the end of the year. Approximate adjusted EBITDA for the first seven months of 2025 is $623,875, and projected annualized adjusted EBITDA for 2025 is $1,100,000.

The agency currently serves over 122 active clients per month and employs 170 direct care professionals. Billing rates vary by payor: $35.95-$42.95 per hour (private pay), $42.68 per hour (VA), $59.50-84.00 per hour (DD Medicaid). An average of 14,600 hours are billed monthly.

Client acquisition is from a variety of referral sources; Current/former clients, discharge planners, geriatric case managers, elder law attorneys

Staff Overview

The owners seek to transition out, while the operating team members are expected to remain post-sale, ensuring operational continuity. This includes a COO and Director of Nursing.

Asking Price

The asking price for this opportunity is $6.6 million.

$6.6 Million Revenue Mobile Wound Care Company Based in the Southwest

American HealthCare Capital is pleased to exclusively present a mobile wound care company for sale in the southwest. The company provides treatment of wounds to patients in the comfort and privacy of their homes, as well as assisted living facilities, skilled nursing facilities, and group homes. With a combination of compassion, quality care, and state of the art technology, they are able to deliver extraordinary results and a healthy recovery for their patients.
Payer Mix and Census
The company’s current payer mix is approximately 85% Medicare and 15% commercial insurance, but they are actively making efforts to contract with additional Medicare Advantage plans. The company currently sees an average of 60 patients per week, and they have the capacity to see additional patients with their existing infrastructure.
Financial Overview
In 2022, they grossed nearly $1.9 million in 2022 with a net income of $172,385. In 2023, they saw astronomical growth, grossing over $9.9 million a strong net income of $1.9 million. In 2024, the company experienced a modest revenue decline due to increased competition, with gross revenue reaching nearly $6.8 million. Since then, revenue has stabilized, and 2025 performance is expected to remain consistent with 2024. Despite this, profitability has strengthened, with adjusted EBITDA projected to exceed $2 million, supported by operational efficiencies and a scalable model that positions the company for continued success.
Staff Overview
The seller is seeking retirement, but the rest of the staff is expected to stay on under new ownership.
Asking Price
The asking price for this opportunity is $8 million.

Leading Multi-State Provider of Pediatric ABA Therapy

American Healthcare Capital is pleased to exclusively represent a rapidly growing, multi-state provider of Applied Behavior Analysis (ABA) therapy services focused on pediatric populations. Founded in 2020, the Company has developed a strong reputation for clinical excellence, scalable operations, and payer diversification, positioning it as an attractive platform for investors seeking exposure to the behavioral health sector.

The Company operates across three U.S. states with full Medicaid certification and commercial payer relationships, delivering individualized ABA therapy to children diagnosed with Autism Spectrum Disorder (ASD). Services are administered by a credentialed network of BCBAs and behavior technicians and include comprehensive behavioral assessments, treatment planning, family training, and virtual social skills groups. As of Q2 2025, the Company has over 180 active clients, with a consistent monthly intake of new patients and strong clinical throughput.

Financial Overview

With a highly efficient service delivery model and strong intake pipeline, the Company has experienced exceptional financial performance:

2022 Revenue: $2.5M | Adj. EBITDA: $570K

2023 Revenue: $4.5M | Adj. EBITDA: $947K

2024 Revenue: $6.7M | Adj. EBITDA: $1.4M

The Company maintains a favorable payer mix led by Medicaid (70%), with the balance from national commercial insurers including Aetna, UnitedHealthcare, BCBS, and Cigna. Its clean compliance record, credentialed staff, and multi-state licensure create a scalable foundation for geographic and service line expansion.

Exit Plan

The founder—an experienced clinician—has built a deep bench of operational talent and is open to remaining post-close to ensure a smooth transition. However, he is actively seeking a partner with the infrastructure and operating expertise to support the Company’s continued expansion.

Asking Price

This opportunity is ideally suited for platform acquisition by a behavioral health-focused private equity group or a strategic consolidator seeking to expand their pediatric therapy footprint with a high-performing, turnkey operation. The asking price is $10 million.